Filing Details

Accession Number:
0001104659-21-108154
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-20 16:05:34
Reporting Period:
2021-08-18
Accepted Time:
2021-08-20 16:05:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609550 Inspire Medical Systems Inc. INSP Surgical & Medical Instruments & Apparatus (3841) 261377674
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817552 Georgia Melenikiotou C/O Inspire Medical Systems, Inc.
5500 Wayzata Blvd., Suite 1600
Golden Valley MN 55416
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-08-18 852 $93.14 1,132 No 4 M Direct
Common Stock Disposition 2021-08-18 852 $207.08 280 No 4 S Direct
Common Stock Disposition 2021-08-19 140 $206.97 140 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2021-08-18 852 $0.00 852 $93.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,982 2030-07-08 No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.96 to $207.20. The reporting person undertakes to provide the Company, any security holder of Inspire Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date.